The balance sheet appears conservatively managed with debt reduced ~40% to $28.8M and a debt-to-equity ratio of 0.17, though the $256.6M accumulated deficit and $0 deferred revenue suggest equity improvement stems from accretion rather than cumulative profitability.
Ceragon Networks Ltd. (CRNT) balance sheet — 27-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 |
|---|
| Total Current Assets | 220.08M | 225.2M | 261.04M | 217.94M | 210.75M | 203.48M | 199.87M | 215.63M | 225.19M | 210.81M | 209.22M | 229.21M | 293.25M | 285.16M | 309.69M | 328.43M | 241.92M | 230.58M | 191.97M | 179.23M | 83.78M | 56.25M | 56.77M | 41.77M | 40.94M | 65.32M | 120.52M | 6.41M |
| Cash & Short-Term Investments | 34.77M | 38.37M | 35.31M | 28.24M | 22.95M | 17.08M | 27.1M | 23.94M | 36.1M | 25.88M | 36.34M | 36.32M | 42.37M | 48.35M | 47.52M | 45.81M | 68.44M | 85.25M | 30.41M | 91.05M | 22.11M | 19.89M | 26.31M | 22.72M | 27.28M | 33.16M | 70.06M | 1.15M |
| Cash Only | 34.77M | 38.37M | 35.31M | 28.24M | 22.95M | 17.08M | 27.1M | 23.94M | 35.58M | 25.88M | 36.34M | 36.32M | 41.42M | 42.41M | 47.1M | 28.99M | 37.73M | 38.34M | 28.22M | 58.65M | 10.17M | 10.31M | 11.23M | 7.31M | 4.69M | 6.42M | 70.06M | 1.15M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 515K | 0 | 0 | 0 | 948K | 5.95M | 422K | 16.82M | 30.72M | 46.91M | 2.19M | 32.4M | 11.94M | 9.57M | 15.07M | 15.42M | 22.6M | 26.74M | 0 | 0 |
| Accounts Receivable | 101.28M | 99.67M | 153.06M | 113.85M | 109.29M | 117.68M | 114.23M | 125.2M | 131.58M | 124.92M | 115.45M | 125.08M | 177.4M | 150.01M | 168.09M | 161.04M | 88.07M | 71.27M | 74.77M | 46.97M | 33.15M | 19.44M | 10.46M | 7.48M | 5.23M | 4.41M | 18M | 2.54M |
| Days Sales Outstanding | 107.2 | 107.4 | 141.72 | 119.7 | 135.14 | 147.73 | 158.61 | 160.01 | 139.67 | 137.32 | 143.51 | 130.65 | 174.48 | 151.35 | 137.36 | 132.01 | 128.66 | 141.2 | 125.61 | 105.91 | 111.59 | 96.16 | 69.66 | 79.3 | 103.74 | 64.83 | 225.09 | 203.59 |
| Inventory | 59.46M | 61.59M | 59.69M | 68.81M | 72.01M | 61.4M | 50.63M | 62.13M | 53.51M | 54.16M | 45.65M | 49.69M | 61.83M | 64.24M | 65.55M | 93.47M | 65.92M | 65.92M | 40.11M | 36.76M | 27.31M | 16.14M | 19.08M | 11.1M | 8.05M | 7.38M | 22.19M | 2.72M |
| Days Inventory Outstanding | 93.63 | 100.28 | 84.67 | 110.49 | 130.04 | 110.73 | 98.69 | 120.16 | 85.77 | 87.98 | 85.67 | 73.58 | 79.56 | 93.96 | 77.6 | 105.56 | 149.94 | 194.85 | 101.25 | 129.77 | 123.41 | 112.27 | 216.37 | 196.29 | 229.83 | 59.46 | 1.3K | 312.45 |
| Other Current Assets | 24.56M | 25.58M | 11.35M | 6.08M | 6.09M | 7.07M | 7.68M | 4.01M | 10.94M | 16.56M | 16.88M | 21.6M | 22.68M | 33.8M | 8.59M | 8.62M | 4.06M | 3.46M | 4.08M | 0 | 0 | 0 | 0 | 0 | 0 | 19.81M | 10.26M | 0 |
| Total Non-Current Assets | 93.7M | 91.84M | 83.96M | 80.58M | 78.57M | 89.08M | 72.55M | 74.25M | 57.81M | 42.78M | 35M | 38.42M | 48.63M | 80.81M | 84.62M | 82.73M | 45.26M | 38.8M | 53.27M | 38.41M | 12.57M | 17.74M | 16.35M | 20.65M | 20.7M | 6.77M | 7.54M | 1.53M |
| Property, Plant & Equipment | 57.07M | 56.51M | 53.47M | 49.5M | 47.42M | 49.62M | 38.53M | 44.99M | 33.61M | 29.87M | 27.56M | 28.91M | 33.14M | 35.24M | 33.64M | 30.46M | 16.21M | 11.81M | 8.89M | 4.45M | 2.66M | 2.46M | 2.52M | 2.67M | 3.62M | 5.09M | 7.01M | 1.29M |
| Fixed Asset Turnover | 6.11x | 5.99x | 7.37x | 7.01x | 6.22x | 5.86x | 6.82x | 6.35x | 10.23x | 11.12x | 10.65x | 12.09x | 11.20x | 10.26x | 13.28x | 14.62x | 15.41x | 15.60x | 24.44x | 36.40x | 40.76x | 29.94x | 21.79x | 12.91x | 5.09x | 4.88x | 4.16x | 3.53x |
| Goodwill | 11.01M | 11.01M | 7.75M | 7.75M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14.94M | 15.28M | 14.59M | 1.09M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 24.52M | 23.18M | 16.79M | 16.4M | 8.21M | 6.27M | 6.12M | 7.9M | 6.58M | 2.2M | 1.54M | 3.19M | 5.07M | 7.21M | 9.81M | 13.44M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 17K | 17K | 504K | 996K | 4.58M | 4.68M | 5.67M | 3.98M | 4.07M | 10.08M | 19.13M | 13.07M | 44.38M | 31M | 7M | 13M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1.1M | 1.14M | 5.95M | 6.94M | 22.95M | 33.19M | 19.61M | 13.24M | 9.64M | 8.73M | 1.31M | 1.46M | 4.51M | 12.89M | 12.13M | 5.26M | 0 | 4.97M | 4.07M | 2.96M | 2.91M | 2.28M | 13.83M | 17.99M | 17.09M | 1.68M | 521K | 237K |
| Total Assets | 313.78M | 317.04M | 345M | 298.52M | 289.32M | 292.56M | 272.42M | 289.89M | 283M | 253.59M | 244.22M | 267.63M | 341.87M | 365.97M | 394.31M | 411.16M | 287.18M | 269.37M | 245.24M | 217.64M | 96.35M | 73.99M | 73.11M | 62.43M | 61.64M | 72.09M | 128.05M | 7.94M |
| Asset Turnover | 1.10x | 1.07x | 1.14x | 1.16x | 1.02x | 0.99x | 0.96x | 0.99x | 1.22x | 1.31x | 1.20x | 1.31x | 1.09x | 0.99x | 1.13x | 1.08x | 0.87x | 0.68x | 0.89x | 0.74x | 1.13x | 1.00x | 0.75x | 0.55x | 0.30x | 0.34x | 0.23x | 0.57x |
| Asset Growth % | -20.73% | -8.1% | 15.57% | 3.18% | -1.11% | 7.39% | -6.03% | 2.43% | 11.6% | 3.84% | -8.75% | -21.72% | -6.58% | -7.19% | -4.1% | 43.17% | 6.61% | 9.84% | 12.68% | 125.88% | 30.22% | 1.21% | 17.11% | 1.28% | -14.49% | -43.7% | 1513.13% | - |
| Total Current Liabilities | 118.79M | 120.23M | 151.45M | 132.95M | 132.84M | 115.68M | 100.42M | 104.37M | 110.02M | 105.45M | 110.51M | 145.2M | 205.5M | 178.4M | 180.67M | 173.44M | 74.41M | 81.29M | 55.67M | 46.81M | 36.51M | 21.38M | 17.94M | 11.29M | 10.55M | 9.96M | 15.96M | 3.05M |
| Accounts Payable | 74.17M | 70.78M | 91.16M | 67.03M | 67.38M | 69.44M | 63.72M | 59.63M | 78.89M | 75.48M | 68.41M | 73.64M | 101.75M | 77.98M | 102.08M | 77.39M | 40.54M | 52.9M | 40.73M | 25.17M | 22.15M | 12.38M | 9.35M | 5.66M | 5.74M | 5.04M | 12.46M | 1.85M |
| Days Payables Outstanding | 111.2 | 115.25 | 129.29 | 107.64 | 121.69 | 125.22 | 124.22 | 115.33 | 126.46 | 122.6 | 128.39 | 109.04 | 130.94 | 114.06 | 120.83 | 87.41 | 92.2 | 156.35 | 102.81 | 88.86 | 100.08 | 86.11 | 105.99 | 100.1 | 163.91 | 40.63 | 731.11 | 212.28 |
| Short-Term Debt | 12M | 23M | 25.2M | 32.6M | 37.5M | 14.8M | 5.98M | 14.6M | 0 | 0 | 17M | 34.92M | 48.83M | 46.92M | 25.23M | 8.23M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 6.99M | 2.37M | 4.31M | 8.79M | 6.95M | 8.43M | 7.84M | 3.46M | 3.87M | 5.19M | 2.67M | 8.9M | 17.67M | 7.97M | 16.72M | 38.31M | 20.66M | 18.55M | 5.89M | 6.7M | 3.74M | 3.46M | 3.11M | 1.19M | 647K | 0 | 0 | 0 |
| Other Current Liabilities | 28.55M | 24.07M | 12M | 6.56M | 2.82M | 2M | 1.55M | 1.56M | 4.2M | 10.44M | 11.33M | 15.7M | 25.86M | 32.44M | 22.89M | 6.66M | 13.21M | 9.85M | 8.04M | 6.17M | 9.23M | 1.99M | 1.73M | 2.55M | 1.93M | 3.07M | 1.7M | 1.2M |
| Current Ratio | 1.85x | 1.87x | 1.72x | 1.64x | 1.59x | 1.76x | 1.99x | 2.07x | 2.05x | 2.00x | 1.89x | 1.58x | 1.43x | 1.60x | 1.71x | 1.89x | 3.25x | 2.84x | 3.45x | 3.83x | 2.29x | 2.63x | 3.16x | 3.70x | 3.88x | 6.56x | 7.55x | 2.10x |
| Quick Ratio | 1.35x | 1.36x | 1.33x | 1.12x | 1.04x | 1.23x | 1.49x | 1.47x | 1.56x | 1.49x | 1.48x | 1.24x | 1.13x | 1.24x | 1.35x | 1.35x | 2.37x | 2.03x | 2.73x | 3.04x | 1.55x | 1.88x | 2.10x | 2.72x | 3.12x | 5.82x | 6.16x | 1.21x |
| Cash Conversion Cycle | 89.64 | 92.43 | 97.09 | 122.55 | 143.5 | 133.23 | 133.08 | 164.84 | 98.98 | 102.7 | 100.79 | 95.19 | 123.11 | 131.25 | 94.12 | 150.16 | 186.4 | 179.7 | 124.05 | 146.82 | 134.92 | 122.32 | 180.04 | 175.49 | 169.66 | 83.67 | 795.7 | 303.76 |
| Total Non-Current Liabilities | 22.94M | 24.06M | 27.22M | 31.55M | 36.7M | 39.73M | 25.87M | 25.1M | 13.41M | 14.24M | 17.55M | 19.61M | 31.82M | 52.5M | 69.77M | 76.66M | 8.6M | 7.17M | 6.65M | 9.94M | 12.28M | 3.42M | 2.99M | 2.45M | 1.82M | 1.51M | 1.02M | 1.56M |
| Long-Term Debt | 0 | 13.33M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.07M | 10.3M | 18.54M | 26.77M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.17M |
| Capital Lease Obligations | 51.44M | 13.33M | 12.94M | 13.72M | 13.19M | 17.21M | 3.84M | 4.72M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28K | 141K | 228K | 185K | 0 | 0 | 0 | 0 | 8.83M | 8.94M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 10.22M | -2.6M | 14.29M | 17.17M | 11.97M | 13.24M | 14.53M | 14.12M | 13.38M | 14.1M | 17.55M | 19.91M | 29.75M | 42.19M | 51.23M | 49.9M | 8.6M | 7.17M | 6.65M | 9.94M | 12.28M | 3.42M | 2.99M | 2.45M | 1.82M | 1.51M | 1.02M | 389K |
| Total Liabilities | 141.73M | 144.29M | 178.67M | 164.51M | 169.53M | 155.41M | 126.29M | 129.47M | 123.43M | 119.69M | 128.06M | 164.81M | 237.32M | 230.89M | 250.44M | 250.11M | 83.01M | 88.47M | 62.32M | 56.75M | 48.79M | 24.8M | 20.92M | 13.74M | 12.37M | 11.47M | 16.98M | 4.61M |
| Total Debt | 28.78M | 49.66M | 41.11M | 50.2M | 54.43M | 36.37M | 13M | 24.96M | 0 | 0 | 17M | 34.92M | 50.9M | 57.23M | 43.77M | 35M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.17M |
| Net Debt | -5.99M | 11.29M | 5.8M | 21.97M | 31.48M | 19.29M | -14.1M | 1.02M | -35.58M | -25.88M | -19.34M | -1.4M | 9.48M | 14.82M | -3.33M | 6.01M | -37.73M | -38.34M | -28.22M | -58.65M | -10.17M | -10.31M | -11.23M | -7.31M | -4.69M | -6.42M | -70.06M | 24K |
| Debt / Equity | 0.17x | 0.29x | 0.25x | 0.37x | 0.45x | 0.27x | 0.09x | 0.16x | - | - | 0.15x | 0.34x | 0.49x | 0.42x | 0.30x | 0.22x | - | - | - | - | - | - | - | - | - | - | - | 0.35x |
| Debt / EBITDA | 1.30x | 1.96x | 0.81x | 1.61x | 528.47x | 2.13x | 2.46x | 1.47x | - | - | 0.58x | 1.03x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | -0.27x | 0.45x | 0.11x | 0.70x | 305.67x | 1.13x | -2.67x | 0.06x | -1.05x | -0.80x | -0.65x | -0.04x | - | - | - | - | -2.02x | -6.46x | -1.88x | -4.41x | - | - | -5.60x | - | - | - | - | - |
| Interest Coverage | 0.75x | 1.11x | 5.56x | 2.69x | -2.44x | 0.17x | -2.12x | 1.09x | 5.66x | 4.57x | 4.63x | 3.05x | -8.10x | -6.78x | -4.76x | -23.69x | 17.84x | 14.85x | 10.42x | - | - | - | - | - | - | - | - | - |
| Total Equity | 172.05M | 172.75M | 166.32M | 134.02M | 119.78M | 137.15M | 146.13M | 160.42M | 159.57M | 133.9M | 116.16M | 102.82M | 104.55M | 135.08M | 143.87M | 161.05M | 204.17M | 180.91M | 182.92M | 160.89M | 47.56M | 49.19M | 52.19M | 48.68M | 49.27M | 60.62M | 111.07M | 3.33M |
| Equity Growth % | 16.22% | 3.86% | 24.11% | 11.88% | -12.66% | -6.14% | -8.91% | 0.53% | 19.17% | 15.27% | 12.98% | -1.66% | -22.6% | -6.11% | -10.67% | -21.12% | 12.86% | -1.1% | 13.69% | 238.29% | -3.31% | -5.74% | 7.2% | -1.18% | -18.73% | -45.42% | 3235.38% | - |
| Book Value per Share | 1.89 | 1.92 | 1.88 | 1.57 | 1.42 | 1.64 | 1.80 | 2.00 | 1.97 | 1.67 | 1.48 | 1.33 | 1.67 | 3.51 | 3.95 | 4.48 | 5.58 | 5.05 | 4.77 | 5.02 | 1.69 | 1.93 | 1.87 | 2.11 | 2.20 | 2.87 | 5.38 | 0.43 |
| Total Shareholders' Equity | 172.05M | 172.75M | 166.32M | 134.02M | 119.78M | 137.15M | 146.13M | 160.42M | 159.57M | 133.9M | 116.16M | 102.82M | 104.55M | 135.08M | 143.87M | 161.05M | 204.17M | 180.91M | 182.92M | 160.89M | 47.56M | 49.19M | 52.19M | 48.68M | 49.27M | 60.62M | 111.07M | 3.33M |
| Common Stock | 234K | 234K | 224K | 224K | 224K | 224K | 218K | 215K | 214K | 214K | 214K | 214K | 212K | 141K | 98K | 97K | 95K | 92K | 91K | 91K | 68K | 65K | 64K | 61K | 56K | 56K | 52K | 16K |
| Retained Earnings | -256.65M | -253.22M | -251.13M | -275.19M | -281.41M | -261.72M | -246.89M | -229.1M | -226.75M | -249.87M | -265.43M | -276.86M | -277.87M | -201.39M | -153.91M | -130.52M | -76.87M | -90.93M | -94.59M | -120.56M | -133.7M | -128.24M | -124.41M | -126.03M | -118.3M | -103.94M | -47.1M | -11.9M |
| Treasury Stock | -20.09M | -20.09M | -20.09M | -20.09M | -20.09M | -20.09M | -20.09M | -20.09M | -20.09M | -20.09M | -20.09M | -20.09M | -20.09M | -20.09M | -20.09M | -20.09M | -20.09M | -20.09M | -7.92M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -9.13M | -8.82M | -10.06M | -8.09M | -11.16M | -9.51M | -8.07M | -8.67M | -9.21M | -7.17M | -7.85M | -8.62M | -4.11M | -1.57M | -332K | -343K | 159K | 100K | 193K | 280K | 64K | 25K | -11K | -395K | -1.77M | -4.85M | -12.23M | -10.27M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying CRNT stock.
As of 2025, Ceragon Networks Ltd. (CRNT) had total assets of $317.0M including $225.2M in current assets.
Ceragon Networks Ltd. (CRNT) carries total debt of $49.7M, offset by $38.4M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Ceragon Networks Ltd. (CRNT) has total shareholders' equity (book value) of $172.8M ($1.92 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Ceragon Networks Ltd. (CRNT) reported a current ratio of 1.87x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Goodwill impairment risk
Balance Sheet Deleveraging Despite Weak Earnings
Ceragon's balance sheet has meaningfully strengthened over ten quarters, with total liabilities declining $37.5M from the $179.2M peak in 2025Q1 to $141.7M in 2026Q2, per reported quarterly balance sheets, even as the retained deficit persists — suggesting liability management, not earnings, is driving improvement.
Total assets contracted roughly 9% from the $346.2M peak in 2025Q1 to $313.8M, yet equity expanded from $135.0M to $172.1M over the same span. This divergence indicates that balance sheet cleanup — primarily debt repayment and working capital normalization — has been the principal driver of equity accretion, not organic profit generation. Given the prior finding of deteriorating operating margins, the trajectory appears sustainable only if revenue recovery materializes.
Conservative Leverage with Active Paydown
Based on Ceragon's reported filings, total debt was reduced approximately 40% from $47.2M in 2024Q1 to $28.8M in 2026Q2, pushing the debt-to-equity ratio down to 0.17 — among the lowest in the peer group — suggesting management is prioritizing balance sheet flexibility over leverage-optimized capital returns.
The sequential debt reduction of $10.9M in 2026Q2 alone reflects meaningful deleveraging, with D/E falling from 0.35 to 0.17 across ten quarters. At roughly 9.2% debt-to-assets, refinancing risk appears negligible based on reported figures. However, the debt paydown has been concurrent with cash decline — cash fell from $39.2M to $34.8M in the same quarter — suggesting the deleveraging may partly reflect working capital absorption rather than surplus free cash flow allocation.
Persistent Deficit Masks Equity Build
According to Ceragon's reported balance sheets, despite equity growing $37.1M over ten quarters to $172.1M, the accumulated retained deficit of -$256.6M in 2026Q2 — only marginally improved from -$274.8M in 2024Q1 — indicates equity improvement stems from accretion effects rather than cumulative profitability.
The $18.2M improvement in retained earnings over the period is modest relative to the $37.1M equity increase, implying that roughly half the equity build stems from non-earnings components such as accumulated comprehensive income or share-based compensation accretion. The equity book value appears to reflect balance sheet hygiene rather than demonstrated earnings power, a distinction that matters given the prior finding of SG&A expanding 70% while revenue contracted 9%.
Improving Ratios Offset by Cash Compression
As reported in quarterly SEC filings, the current ratio improved to 1.85 in 2026Q2 from 1.70 in 2024Q1, yet cash declined $4.4M sequentially to $34.8M — the second consecutive quarterly drawdown — warranting monitoring of near-term buffer adequacy.
The liquidity position appears adequate on headline metrics, with the current ratio now exceeding most peers including Aviat (1.64) and EchoStar (0.42). However, the simultaneous improvement in current ratio alongside cash compression suggests that the ratio improvement may be driven by liability paydown reducing current liabilities rather than by asset-side liquidity accumulation. If the working capital reversal identified in cash flow analysis persists, the cash cushion could tighten without a corresponding current ratio deterioration — potentially masking reduced flexibility.
Deferred Revenue Evaporated to Zero
According to Ceragon's quarterly balance sheets, deferred revenue fell from $4.9M in 2024Q1 to $0 in 2026Q2 — a complete elimination of contract-based forward revenue recognition — leaving no visible indicator of contracted future revenue to corroborate the top-line recovery.
The progressive decline from $4.3M in 2024Q4 to zero by 2026Q2 is notable given that revenue is nominally recovering — up 14.2% year-over-year per income statement findings. This suggests the revenue rebound may be driven by spot or short-cycle orders rather than multi-period contractual commitments, which historically carry higher revenue quality. Investors should treat the absence of deferred revenue as a caution that the reported recovery lacks balance-sheet-level corroboration of forward demand visibility.
Acquired Goodwill Outgrew the Earnings Base
As disclosed in Ceragon's reported balance sheets, goodwill rose 43% from $7.7M in 2024Q4 to $11.0M in 2025Q4 while revenue contracted 9% over the same span, a divergence that may indicate acquisition-driven intangibles carry impairment risk absent operating leverage.
The $3.3M goodwill step-up coincides with the $6.6M of net acquisitions recorded in 2025Q1 cash flow statements, meaning roughly half of that outlay now sits as an unverifiable intangible against a business whose operating margin collapsed from 14.3% to 0.3% over the period. Meanwhile PPE net climbed to $57.1M — about 18% of total assets — even as total assets shrank 9% from peak, implying capital is accumulating in fixed and acquired assets faster than the revenue base can support them. This is the distortion most likely to make the headline 0.17 D/E and 1.85 current ratio look healthier than the underlying asset productivity warrants.